Raymond James Financial’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDX
ACA
CIA
CAI
SIC
KA
Raymond James Financial's IBDX Position: Q2 2026 in Review
Raymond James Financial increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 60% in Q2 2026, buying an estimated $11M and bringing the position to 1,161,884 shares worth $29.3M. The position accounts for 0.01% of the portfolio, ranked #1300.
Raymond James Financial first reported a position in IBDX in Q4 2024 and has held it in 7 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.
- Raymond James Financial held 1,161,884 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $29.3M as of Q2 2026.
- Raymond James Financial bought 436,626 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $11M.
- iShares iBonds Dec 2032 Term Corporate ETF made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1300 holding.
- Raymond James Financial first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2024 and has held it in 7 quarters since.
- 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.
Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.